Inflammatory Cytokines Determine the Susceptibility of Human CD8 T Cells to Fas-mediated Activation-induced Cell Death Through Modulation of FasL and C-FLIP(S) Expression
Overview
Affiliations
The nature of inflammatory signals determines the outcome of T cell responses. However, little is known about how inflammatory cytokines provided to human CD8 T cells during activation affects their susceptibility to post-activation cell death. We have examined and compared the effects of the inflammatory cytokine IL-12, as well as the combination of IL-1, IL-6, and IL-23 (IL-1/6/23) on the susceptibility of primary human CD8 T cells to post-activation cell death. Human CD8 T cells activated in the presence of IL-1/6/23 underwent significantly less cell death after activation as compared with those activated in IL-12. This was due to reduced susceptibility to Fas-mediated activation-induced cell death (AICD). Mechanistically, the reduced level of cell death in CD8 T cells activated in IL-1/6/23 was a result of a low level of FasL expression and high level of c-FLIP(S) expression. When the effect of IL-1, IL-6, and IL-23 individually was examined, IL-1 or IL-6 alone was sufficient to inhibit CD8 T cell death that occurs after activation in IL-12. IL-1, but not IL-6, inhibited expression of FasL, whereas IL-6, but not IL-1, increased c-FLIP(S) expression. Our findings show that the presence of IL-1 and/or IL-6 during activation of human CD8 T cells attenuates Fas-mediated AICD, whereas IL-12 increases the susceptibility of activated CD8 T cells to this form of cell death.
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities.
Nova Z, Zemanek T, Botek N Int J Mol Sci. 2022; 23(23).
PMID: 36499448 PMC: 9737069. DOI: 10.3390/ijms232315122.
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.
Reinke S, Thakur A, Gartlan C, Bezbradica J, Milicic A Vaccines (Basel). 2020; 8(3).
PMID: 32971761 PMC: 7565252. DOI: 10.3390/vaccines8030554.
Wang X, Li J, Liu D, Zhang L, Zhao B, Tang J Int J Clin Exp Pathol. 2020; 11(4):2201-2213.
PMID: 31938332 PMC: 6958188.
Stacey M, Clare S, Clement M, Marsden M, Abdul-Karim J, Kane L J Clin Invest. 2017; 127(4):1463-1474.
PMID: 28240600 PMC: 5373880. DOI: 10.1172/JCI84889.
Noval Rivas M, Lee Y, Wakita D, Chiba N, Dagvadorj J, Shimada K Arthritis Rheumatol. 2016; 69(2):410-421.
PMID: 27696768 PMC: 5274597. DOI: 10.1002/art.39939.